PERICARDIAL TUBERCULOSIS IN A PATIENT WITH REFRACTORY PERICARDIAL EFFUSION AND USE OF DASATINIB: CASE REPORT

Abstract: Cardiovascular events have been reported in patients with chronic myeloid leukemia (CML) using tyrosine kinase inhibitors (TKIs). This study reports the occurrence of pericardial effusion (PE) refractory to usual therapy, with a final diagnosis of extrapulmonary tuberculosis (TB). Introduc...

Full description

Bibliographic Details
Published in:Hematology, Transfusion and Cell Therapy
Main Authors: YVS Oliveira, IR Barbosa, MFR Dezan, LS Lopes, TR Farina, RL Uliano, LM Oliveira, LC Palma
Format: Article
Language:English
Published: Elsevier 2024-10-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924011830